SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-040203
Filing Date
2023-03-31
Accepted
2023-03-31 16:18:39
Documents
1
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2311075-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2311075-4_4seq1.xml 4 4012
  Complete submission text file 0001104659-23-040203.txt   5509
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATRINSIC, INC. 1 GRAND CENTRAL PLACE SUITE 2319 NEW YORK NY 10165
Business Address
SCHECHTER JONATHAN (Reporting) CIK: 0001619259 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40458 | Film No.: 23787993